Co-infection of mucormycosis and aspergillosis in post COVID-19 patient: A concerning rare case report during second wave of COVID-19 pandemic

---

Case Report

Author Details : Vikramjeet Singh, Anupam Das*, Nikhil Gupta, Ashish Chandra Agarwal, Tushar Gautam, Nikhil Raj, Jaya Garg, Manodeep Sen, Jyotsna Agarwal

Volume : 7, Issue : 4, Year : 2021

Article Page : 300-303

https://doi.org/10.18231/j.ijmmtd.2021.062

Suggest article by email

Get Permission

---

Abstract

COVID-19 manifestations have been evolving and affect different parts of the body every time a new wave comes. Association of mucormycosis in COVID-19, Covid Associated Mucormycosis (CAM) affected patients especially affecting paranasal sinuses must be given serious and timely consideration. Prolonged history of uncontrolled diabetes and over the counter use of steroids and abrupt stoppage of steroids are two main factors aggravating the illness, and both these factors must be critically checked. Clinical condition like Mucormycosis are caused by pathogenic moulds of family Mucorales and Aspergillosis is caused by Aspergillus species and both can cause an invasive disease with high case fatality rate, especially in immunosuppressed patients. In the present study we are discussing a case of co-infection in Post COVID-19 patient affected with mucormycosis and aspergillosis. A 55-year-old male patient with Type 2 diabetes mellitus presented post covid with ptosis and diplopia. Mixed infections of Rhizopus arrhizus and Aspergillus flavus were diagnosed by means of fungal microscopy and culture from biopsy sample. Treatment with Amphotericin B was started, the patient responded clinically within 15 days.
 

Keywords: Post COVID­19, Aspergillosis, diabetes mellitus, immunocompromised, mucormycosis, steroids

How to cite : Singh V, Das A, Gupta N, Agarwal A C, Gautam T, Raj N, Garg J, Sen M, Agarwal J, Co-infection of mucormycosis and aspergillosis in post COVID-19 patient: A concerning rare case report during second wave of COVID-19 pandemic. IP Int J Med Microbiol Trop Dis 2021;7(4):300-303

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.